|
FOR IMMEDIATE RELEASE MAR 29, 2006
Contact: William Couch (888) 697-9996
NASA Scientist Dr. Thomas Goodwin to Present Data on Growing Human Brain from Precursor Cells at Harborview Medical Center
Dr. Thomas Goodwin, project scientist for NASA's
Integrated Cell Science Project, has been invited by the University of
Washington to share his research data on using nanosecond pulsed
electromagnetic field technology to grow brain tissue from human brain
cells harvested at the time of surgery. After introduction by Puget
Sound biotech founder, Dr. Glen Gordon of EM-PROBE Technologies, Dr.
Goodwin will address Harborview's neurosurgery grand rounds on April
12, 2006 at 8:00 a.m. pt.
Dr. Gordon, who began studying nanosecond pulsed electromagnetic
technology in humans in 1980, suggested Dr. Goodwin's study to members
of the University of Washington Department of Neurosurgery during
discussions of EM-PROBE Technologies' similar nanosecond technology to
restore tissues after trauma. Dr. Gordon met Dr. Goodwin in 2003 and
assisted his presentation at The Annual Meeting of the American
College of Sports Medicine in 2005. The four year study, published in
2003 as NASA Technical Paper 2003-212054, is available online at
EM-PROBE Technologies' site, www.em-probe.com under "NASA Study." Dr.
Gordon, the original investigator of nPEMF in the US, considers Dr.
Goodwin's data "a seminal study defining the efficacy of this and
other technologies alleged to restore tissues following trauma".
Dr. Goodwin's presentation, "Metabolic and Genetic Effects of Time
Varying Electromagnetic Fields" will discuss the capacity of
nanosecond pulsed electromagnetic fields to stimulate classes of
growth and restoration genes in human brain tissue.
About EM-PROBE Technologies
Sports medicine specialist and researcher, Dr. Glen Gordon founded EM-PROBE Technologies in 2001. Dr. Gordon, the first MD in the United States approved to treat humans with soft tissue injury and arthritis using nanosecond pulsed electromagnetic field technology, chaired the first symposium on free radical damage in sports injury presented at an annual meeting of The American College of Sports Medicine. An invited speaker at a 2006 W.H.O. international meeting on integrative medicine, he conducts research on his company's miniaturized, FDA-approved, hand held device, the result of 25 years of research and development. The company also provides information on PEMF technology and clinical studies through its Web site. For more information about EM-PROBE Technologies, please visit www.em-probe.com, or call 1-888-697-9996.
|
